Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02175446
Brief Title: Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients (GIM11-BERGI)

First Submitted : June 9, 2014
First Submitted that Met QC Criteria : June 25, 2014
First Posted : June 26, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : June 14, 2016
Last Update Posted : June 15, 2016 (Estimate)